DORIA

Pharmaceutical products, namely, chemical-pharmaceuticals for the treatment of central nervous system diseases, namely, psychosis, anxiety and schizophrenia; pharmaceuticals, namely, anxiolytics, antipsychotics; syringes for medical purposes sold filled with pharmaceuticals for treating psychosis, anxiety and schizophrenia; vials for medical purposes sold filled with pharmaceuticals for treating psychosis, anxiety and schizophrenia; cartridges sold filled with pharmaceuticals for treating schizophrenia; ampules sold filled with pharmaceuticals for the treatment of psychosis, anxiety and schizophrenia; implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceutical preparations for psychosis, anxiety and schizophrenia; implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceuticals for sustained release of medicines for treating psychosis, anxiety and schizophrenia; preparations for the treatment of central nervous system diseases; preparations for the treatment of psychosis, anxiety and schizophrenia; sanitary preparations for medical use; dietetic foods adapted for medical use; dietary supplements for humans; plasters for medical purposes